Le Lézard
Classified in: Health
Subject: AVO

14 Patient Groups Oppose New Administration Rule on Public Charge


WASHINGTON, Aug. 12, 2019 /PRNewswire/ -- Today, the Department of Homeland Security (DHS) finalized a new rule that will deter use of vital services for some immigrant populations.

Fourteen patient groups released the following statement in response to this rule being finalized:

"Our organizations represent millions of patients and consumers, including many who have immigrated to the United States, who face serious, acute, and chronic health conditions. Together, we have a unique perspective on what individuals and families living in the United States need to prevent disease, cure illness, have healthy pregnancies, and manage chronic health conditions including disability. We have grave concerns about the long term impacts this rule will have on the health and well-being of individuals and communities we represent.

"This rule directs DHS to broadly expand the public charge evaluation?which aims to determine whether an individual is likely to become dependent on the government for subsistence?to include critical safety-net programs such as Medicaid, the Supplemental Nutrition Assistance Program (SNAP), and Section 8 housing assistance programs for which many immigrants are currently eligible and rely upon. This policy will not only penalize immigrants for using public benefits for which they legally qualify, it will likely have a chilling effect for immigrant communities across all public programs, resulting in fewer people seeking out the support services they and their U.S. citizen family members need and for which they qualify. A recent survey demonstrated that the debate over this issue has already led one in seven adults in immigrant families to forgo public benefits for which they or their children were eligible, including Medicaid and Children's Health Insurance Program. Penalizing and stigmatizing use of these programs could seriously jeopardize the health and well-being of legal immigrants and their U.S. citizen children, spouses, and relatives.

"We are united in our strong opposition to this rule, given the negative impact it is likely to have on the health and wellbeing of the people we represent."

American Heart Association
American Liver Foundation
American Lung Association
Cystic Fibrosis Foundation
Family Voices
Hemophilia Federation of America
Leukemia & Lymphoma Society
Lutheran Services in America
March of Dimes
National Hemophilia Foundation
National Multiple Sclerosis Society
National Patient Advocate Foundation
Susan G. Komen
WomenHeart: The National Coalition for Women with Heart Disease

For media inquiries please contact:
Suniti Sarah Bal: 916-390-1860; [email protected]

SOURCE The Leukemia & Lymphoma Society


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Bristol Myers Squibb today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia (ozanimod) in adult patients with moderate to...

at 16:05
Personalis, Inc. , a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time. About Personalis, Inc....

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...

at 16:05
Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial...

at 16:05
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2023...



News published on and distributed by: